(Q33364817)

26 July 2017

1 reference

title

Benefit-risk assessment of sirolimus in renal transplantation (English)

1 reference

26 July 2017

1 reference

Dirk R J Kuypers

1

1 reference

26 July 2017

1 January 2005

1 reference

26 July 2017

1 reference

26 July 2017

28

1 reference

26 July 2017

153-181

1 reference

26 July 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200528020-00006

26 July 2017

0 references

cites work

Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200528020-00006

The influence of the rapamycin-derivate SDZ RAD on the healing of airway anastomoses

21 January 2018

1 reference

12 December 2020

Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels

1 reference

12 December 2020

Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells

1 reference

12 December 2020

De novo hemolytic-uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: role of sirolimus

1 reference

12 December 2020

The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies

1 reference

12 December 2020

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

1 reference

12 December 2020

Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.

1 reference

12 December 2020

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

1 reference

12 December 2020

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

12 December 2020

Sirolimus-associated pulmonary toxicity

1 reference

12 December 2020

Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure

1 reference

12 December 2020

The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.

1 reference

12 December 2020

Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation

1 reference

12 December 2020

Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation

1 reference

12 December 2020

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

1 reference

12 December 2020

The natural history of chronic allograft nephropathy

1 reference

12 December 2020

Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel

1 reference

12 December 2020

Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function

1 reference

12 December 2020

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies

1 reference

12 December 2020

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

12 December 2020

Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation

1 reference

12 December 2020

Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit

1 reference

12 December 2020

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

1 reference

12 December 2020

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience

1 reference

12 December 2020

Sirolimus rescue therapy for refractory rejection in renal transplantation

1 reference

12 December 2020

Sirolimus rescue treatment in calcineurin-inhibitor nephrotoxicity after kidney transplantation

1 reference

12 December 2020

A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.

1 reference

12 December 2020

Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation

1 reference

12 December 2020

Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1.

1 reference

12 December 2020

Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility

1 reference

12 December 2020

Rapamycin inhibits GM-CSF-induced neutrophil migration

1 reference

12 December 2020

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

1 reference

12 December 2020

Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years

1 reference

12 December 2020

The trouble with kidneys derived from the non heart-beating donor: a single center 10-year experience

1 reference

12 December 2020

Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model

1 reference

12 December 2020

Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients

1 reference

12 December 2020

The effect of rapamycin on kidney function in the Sprague-Dawley rat.

1 reference

12 December 2020

Bone mineral density changes within six months of renal transplantation

1 reference

12 December 2020

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

1 reference

12 December 2020

Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice

1 reference

12 December 2020

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

1 reference

12 December 2020

Thrombotic microangiopathy after renal transplantation in the United States

1 reference

12 December 2020

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

1 reference

12 December 2020

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

1 reference

12 December 2020

Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1

1 reference

12 December 2020

Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative

1 reference

12 December 2020

Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients

1 reference

12 December 2020

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

1 reference

12 December 2020

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

1 reference

12 December 2020

Testosterone concentrations and sirolimus in male renal transplant patients.

1 reference

12 December 2020

Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a Single-Center experience

1 reference

12 December 2020

Sirolimus: a single center experience in combination with calcineurin inhibitors.

1 reference

12 December 2020

Sirolimus-induced leukocytoclastic vasculitis: the second case reported

1 reference

12 December 2020

Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study

1 reference

12 December 2020

Early experience with sirolimus in lung transplant recipients with chronic allograft rejection

1 reference

12 December 2020

Functional and histopathologic effects of rapamycin on mouse kidney

1 reference

12 December 2020

A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year

1 reference

12 December 2020

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

1 reference

12 December 2020

The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients

1 reference

12 December 2020

Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

1 reference

12 December 2020

Sirolimus may promote thrombotic microangiopathy

1 reference

12 December 2020

Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.

1 reference

12 December 2020

Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients—a single center experience

1 reference

12 December 2020

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

1 reference

12 December 2020

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

1 reference

12 December 2020

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions

1 reference

12 December 2020

Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation

1 reference

12 December 2020

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

1 reference

12 December 2020

Immunosuppressant use without bone loss--implications for bone loss after transplantation

1 reference

12 December 2020

A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection

1 reference

12 December 2020

Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin

1 reference

12 December 2020

Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications

1 reference

12 December 2020

Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study

1 reference

12 December 2020

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

12 December 2020

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

1 reference

12 December 2020

Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs

1 reference

12 December 2020

Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro

1 reference

12 December 2020

Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin).

1 reference

12 December 2020

Hypertriglyceridemia in renal transplant recipients treated with sirolimus

1 reference

12 December 2020

Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation

1 reference

12 December 2020

Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model

1 reference

12 December 2020

Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients

1 reference

12 December 2020

Sirolimus improves the two-year outcome of renal allografts in African-American patients

1 reference

12 December 2020

Sirolimus impairs gonadal function in heart transplant recipients

1 reference

12 December 2020

Sirolimus inhibits oxidative burst activity in transplant recipients.

1 reference

12 December 2020

Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro

1 reference

12 December 2020

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

1 reference

12 December 2020

Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus

1 reference

12 December 2020

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus

1 reference

12 December 2020

The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials

1 reference

12 December 2020

Drug points: Premature osteonecrosis and sirolimus treatment in renal transplantation

1 reference

12 December 2020

Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.

1 reference

12 December 2020

Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination

1 reference

12 December 2020

Predictors of renal transplant histology at three months

1 reference

12 December 2020

Alterations of the female reproductive system in recipients of islet grafts

1 reference

12 December 2020

Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation

1 reference

12 December 2020

The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy

1 reference

12 December 2020

Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients

1 reference

12 December 2020

Conversion to sirolimus in solid organ transplantation: a Single-Center experience

1 reference

12 December 2020

Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations

1 reference

12 December 2020

Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients

1 reference

12 December 2020

Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.

1 reference

12 December 2020

Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication?

1 reference

12 December 2020

Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated

1 reference

12 December 2020

Preclinical results of sirolimus treatment in transplant models

1 reference

12 December 2020

Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity

1 reference

12 December 2020

Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model

1 reference

12 December 2020

De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.

1 reference

12 December 2020

Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.

1 reference

12 December 2020

Rapamycin is an effective inhibitor of human renal cancer metastasis.

1 reference

12 December 2020

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

12 December 2020

A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function

1 reference

12 December 2020

Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production

1 reference

12 December 2020

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal

1 reference

12 December 2020

Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model

1 reference

12 December 2020

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience

1 reference

12 December 2020

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

12 December 2020

Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction

1 reference

12 December 2020

Sirolimus-associated eyelid edema in kidney transplant recipients

1 reference

12 December 2020

Sirolimus-tacrolimus combination immunosuppression

1 reference

12 December 2020

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

12 December 2020

Living-donor kidney transplantation at Mayo Clinic--Rochester

1 reference

12 December 2020

Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient

1 reference

12 December 2020

Molecular actions of sirolimus: sirolimus and mTor

1 reference

12 December 2020

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

1 reference

12 December 2020

A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients

1 reference

12 December 2020

New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.

1 reference

12 December 2020

Therapeutic monitoring of sirolimus: its contribution to optimal prescription.

1 reference

12 December 2020

Rapamycin in lung transplantation: preliminary results

1 reference

12 December 2020

Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients

1 reference

12 December 2020

Rapamycin-induced oligospermia

1 reference

12 December 2020

Effect of histological damage on long-term kidney transplant outcome

1 reference

12 December 2020

A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients

1 reference

12 December 2020

Mechanism of action of the immunosuppressant rapamycin

1 reference

12 December 2020

Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction

1 reference

12 December 2020

Sirolimus and lymphocele formation after kidney transplantation: an immunosuppressive medication as co-factor for a surgical problem?

1 reference

12 December 2020

Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients

1 reference

12 December 2020

Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone

1 reference

12 December 2020

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors

1 reference

12 December 2020

Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients

1 reference

12 December 2020

Pneumonitis associated with the use of mycophenolate mofetil

1 reference

12 December 2020

Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats

1 reference

12 December 2020

Case report--sirolimus rescue therapy for refractory renal allograft rejection

1 reference

12 December 2020

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

12 December 2020

Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation

1 reference

12 December 2020

Sirolimus-induced angioedema

1 reference

12 December 2020

Clinical epidemiology of cardiac disease in renal transplant recipients

1 reference

12 December 2020

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

12 December 2020

Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients

1 reference

12 December 2020

Kidney transplantation without calcineurin inhibitors using sirolimus.

1 reference

12 December 2020

Pediatric utilization of rapamycin for severe cardiac allograft rejection

1 reference

12 December 2020

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

1 reference

12 December 2020

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience

1 reference

12 December 2020

Rapamycin: signaling in vascular smooth muscle

1 reference

12 December 2020

1 reference

12 December 2020

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

12 December 2020

Pharmacokinetics of tacrolimus-based combination therapies

1 reference

12 December 2020

Lymphedema associated with sirolimus in renal transplant recipients.

1 reference

12 December 2020

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

1 reference

12 December 2020

Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity

1 reference

12 December 2020

Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience

1 reference

12 December 2020

Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression

1 reference

12 December 2020

Sirolimus-induced pneumonitis: three cases and a review of the literature

1 reference

12 December 2020

Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation

1 reference

12 December 2020

Sirolimus-based immunosuppression for transplant-associated thrombotic microangiopathy

1 reference

12 December 2020

Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation

1 reference

12 December 2020

Management of lymphoceles after kidney transplantation

1 reference

12 December 2020

Effect of rapamycin and FK506 on mesangial cell proliferation

1 reference

12 December 2020

Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.

1 reference

12 December 2020

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

1 reference

12 December 2020

Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil

1 reference

12 December 2020

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

12 December 2020

Interstitial granulomatous pneumonitis associated with sirolimus in a child after liver transplantation

1 reference

12 December 2020

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients

1 reference

12 December 2020

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

1 reference

12 December 2020

Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients

1 reference

12 December 2020

Acute effects of rapamycin on glomerular dynamics: a micropuncture study in the rat

1 reference

12 December 2020

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

12 December 2020

Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.

1 reference

12 December 2020

Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange

1 reference

12 December 2020

Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation

1 reference

12 December 2020

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

1 reference

12 December 2020

Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies

1 reference

12 December 2020

Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation

1 reference

12 December 2020

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

1 reference

12 December 2020

The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand

1 reference

12 December 2020

Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury

1 reference

12 December 2020

Human herpesvirus-6 in renal transplant recipients: potential risk factors for the development of human herpesvirus-6 seroconversion.

1 reference

12 December 2020

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

1 reference

12 December 2020

Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.

1 reference

12 December 2020

Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient

1 reference

12 December 2020

Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients

1 reference

12 December 2020

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

1 reference

12 December 2020

Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus

1 reference

12 December 2020

Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation

1 reference

12 December 2020

Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study

1 reference

12 December 2020

Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients

1 reference

12 December 2020

Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates

1 reference

12 December 2020

Sirolimus: its discovery, biological properties, and mechanism of action

1 reference

12 December 2020

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

12 December 2020

Sirolimus-induced leukocytoclastic vasculitis

1 reference

12 December 2020

Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR

1 reference

12 December 2020

Effects of rapamycin on cultured hepatocyte proliferation and gene expression

1 reference

12 December 2020

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

1 reference

12 December 2020

Post-renal transplant syndrome of transient lower limb joint pain: description under a tacrolimus-based immunosuppression.

1 reference

12 December 2020

Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression

1 reference

12 December 2020

Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine.

1 reference

12 December 2020

Renal effects of rapamycin in the spontaneously hypertensive rat

1 reference

12 December 2020

A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function

1 reference

12 December 2020

Diabetes mellitus after kidney transplantation in the United States

1 reference

12 December 2020

Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia

1 reference

12 December 2020

Death with functioning graft--a preventable cause of graft loss.

1 reference

12 December 2020

Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes

1 reference

12 December 2020

Are wound complications after a kidney transplant more common with modern immunosuppression?

1 reference

12 December 2020

Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria

1 reference

12 December 2020

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

1 reference

12 December 2020

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination

1 reference

12 December 2020

Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients

1 reference

12 December 2020

De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco

1 reference

12 December 2020

Clinical pharmacokinetics of sirolimus

1 reference

12 December 2020

Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study

1 reference

12 December 2020

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

1 reference

12 December 2020

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

1 reference

12 December 2020

Enhancement of human platelet aggregation and secretion induced by rapamycin

1 reference

12 December 2020

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

1 reference

12 December 2020

European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients

1 reference

12 December 2020

10.2165/00002018-200528020-00006

Identifiers

DOI

1 reference

PubMed ID

15691225

Dimensions Publication ID

26 July 2017

0 references

1 reference

PubMed ID

15691225